General, page-621

Should be interesting what the opinion is of the undertheradarreport tomorrow morning. I don't have a subscription anymore. They have recently ie last year been in favour of IPD.

Research tip updates on long-term favourites
But wait, there’s more! We look at a couple of long-term favourites that havehad recent spikes, Centrepoint Financial (CAF) up 31% yesterday and the med-tech Cyclopharm (CYC) which is looking tohit the giant US market at pace with its nuclear based diagnostic technologyfor pulmonary embolism. We run the ruler over another med-tech, ImpediMed (IPD), a buynowpaylaterspecialist, our friends at a Chinese based electric scooter manufacturer andanother med-tech, Volpara Health (VHT) which announced an acquisition this week.